- Home
- ILAG vs PSTV Comparison
ILAG vs PSTV Comparison
Compare ILAG & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- PSTV
- Stock Information
- Founded
- ILAG 1981
- PSTV 1996
- Country
- ILAG Hong Kong
- PSTV United States
- Employees
- ILAG N/A
- PSTV N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- PSTV Medical/Dental Instruments
- Sector
- ILAG Consumer Discretionary
- PSTV Health Care
- Exchange
- ILAG Nasdaq
- PSTV Nasdaq
- Market Cap
- ILAG 9.4M
- PSTV 10.4M
- IPO Year
- ILAG 2022
- PSTV N/A
- Fundamental
- Price
- ILAG $0.54
- PSTV $0.34
- Analyst Decision
- ILAG
- PSTV Strong Buy
- Analyst Count
- ILAG 0
- PSTV 3
- Target Price
- ILAG N/A
- PSTV $10.83
- AVG Volume (30 Days)
- ILAG 420.6K
- PSTV 65.4M
- Earning Date
- ILAG 07-22-2025
- PSTV 08-13-2025
- Dividend Yield
- ILAG N/A
- PSTV N/A
- EPS Growth
- ILAG N/A
- PSTV N/A
- EPS
- ILAG N/A
- PSTV N/A
- Revenue
- ILAG $7,506,551.00
- PSTV $5,206,000.00
- Revenue This Year
- ILAG N/A
- PSTV $14.10
- Revenue Next Year
- ILAG N/A
- PSTV $7.96
- P/E Ratio
- ILAG N/A
- PSTV N/A
- Revenue Growth
- ILAG 16.50
- PSTV N/A
- 52 Week Low
- ILAG $0.34
- PSTV $0.16
- 52 Week High
- ILAG $1.35
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- ILAG 56.92
- PSTV 49.71
- Support Level
- ILAG $0.48
- PSTV $0.27
- Resistance Level
- ILAG $0.52
- PSTV $0.37
- Average True Range (ATR)
- ILAG 0.04
- PSTV 0.05
- MACD
- ILAG -0.01
- PSTV 0.01
- Stochastic Oscillator
- ILAG 80.48
- PSTV 61.59
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).